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The cannabinoid, cannabidiol (CBD), is part of the plant’s natural defense system that
when given to animals has many useful medicinal properties, including activity against
cancer cells, modulation of the immune system, and efficacy in epilepsy. Although there is
no consensus on its precise mode of action as it affects many cellular targets, CBD does
appear to influence mitochondrial function. This would suggest that there is a cross-
kingdom ability to modulate stress resistance systems that enhance homeostasis. As
NAD(P)H autofluorescence can be used as both a metabolic sensor and mitochondrial
imaging modality, we assessed the potential of this technique to study the in vitro effects of
CBD using 2-photon excitation and fluorescence lifetime imaging microscopy (2P-FLIM) of
NAD(P)H against more traditional markers of mitochondrial morphology and cellular stress
in MCF7 breast cancer cells. 2P-FLIM analysis revealed that the addition of CBD induced a
dose-dependent decrease in bound NAD(P)H, with 20 µM treatments significantly
decreased the contribution of bound NAD(P)H by 14.6% relative to the control (p <
0.001). CBD also increased mitochondrial concentrations of reactive oxygen species
(ROS) (160 ± 53 vs. 97.6 ± 4.8%, 20 µMCBD vs. control, respectively, p < 0.001) and Ca2+
(187 ± 78 vs. 105 ± 10%, 20 µM CBD vs. the control, respectively, p < 0.001); this was
associated with a significantly decreased mitochondrial branch length and increased
fission. These are all suggestive of mitochondrial stress. Our results support the use of
NAD(P)H autofluorescence as an investigative tool and provide further evidence that CBD
can modulate mitochondrial function and morphology in a dose-dependent manner, with
clear evidence of it inducing oxidative stress at higher concentrations. This continues to
support emerging data in the literature and may provide further insight into its overall mode
of action, not only in cancer, but potentially its function in the plant and why it can act as a
medicine.
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INTRODUCTION
Uncontrolled cell growth, or cancer, is frequently associated with
increased aerobic glycolysis (the Warburg effect) and alterations in
mitochondrial function (Trigos et al., 2018). A plant’s ability to
develop tumors could explain why so many secondary plant
phenolic compounds appear to have anticancer activity in both
plant and animal models (Rasouli et al., 2016); over 3,000 species of
plants have anticancer activity in animals, with many modulating
mitochondrial function and apoptosis (Gali-Muhtasib et al., 2015).
Due to the similarities between plant and animal metabolism,
many plant compounds can be considered mitochondrially
targeted drugs for treating cancer (Gorlach et al., 2015). In
plants, mitochondria are central in managing oxidative stress
via thermodynamic buffering, involving enhancement of
antioxidant capacity and uncoupling, as well as detoxification
and induction of programmed cell death (Popov, 2020; Gandin
et al., 2021). This is supported by evidence that some bioactive
plant compounds can protect plant mitochondria (Laus and
Soccio, 2020). Critically, the stress response system has to not
only be adaptive and protect cells but also induce cell death when
necessary, suggesting a biphasic or hormetic dose–response curve.
One such compound, cannabidiol (CBD), has demonstrated a
plethora of pharmacological effects ranging from anti-
inflammatory to anxiolytic, antiepileptic, anticancer, and even
antibacterial (Mechoulam et al., 2002; Gray et al., 2020; Kis
et al., 2019). However, there is still no clear consensus on its
mode of action. Rather than focusing on individual receptors and
channels, here we investigate how it might modulate a key nexus in
cell function, the mitochondrion.
CBD, along with Δ9-tetrahydrocannabinol (THC), is a major
phytocannabinoid and both are well described components of
medicines. Unlike THC, CBD is not psychoactive and is now
being used to treat epilepsy (O’Connell et al., 2017; Baker et al.,
2000). A growing number of studies have demonstrated the
anticancer properties of CBD, in both in vitro and in vivo models
(Ramer and Hinz, 2017; Kis et al., 2019). Proposed mechanisms
include induction of autophagy and mitochondrial-mediated
apoptosis and inhibition of exosome and microvesicle release
(Shrivastava et al., 2011; Armstrong et al., 2015; McAllister et al.,
2015; Kosgodage et al., 2018). Although the exact cellular
mechanisms by which CBD exerts its effects remain unclear
(Ibeas Bih et al., 2015), one potential mechanism may relate to its
ability to interact with the voltage-dependent anion channel 1
(VDAC1) (Rimmerman et al., 2013), which is central to metabolic
reprogramming, apoptosis, and a cancer drug target (Shoshan-
Barmatz et al., 2018). VDAC1 is also important in controlling
mitochondrial morphology as part of the mitochondrial-associated
membrane (MAM) complex and a key controller of calcium flux
(Giorgi et al., 2015). Critically, cancer cells modulate mitochondrial
dynamics to resist apoptosis (Senft and Ronai, 2016). We have
preliminary data that indicate that CBD modulates mitochondrial
dynamics (Nunn et al., 2013), supported by recent studies which
suggest CBDmodulates themembrane order and induces cholesterol
biosynthesis (Guard et al., 2020).
Another important target for CBD, the transient receptor
potential vanilloid 1 (TRPV1) (Bisogno et al., 2001; Iannotti
et al., 2014) is critical in calcium signaling and can lead to its
accumulation by mitochondria (Bujak et al., 2019). CBD
stimulates neuronal survival in models of Parkinson’s disease
via the protein kinase B/mammalian target of rapamycin (AKT/
mTOR) pathway through a mechanism involving TRPV1
(Gugliandolo et al., 2020) and can also induce cancer cell
death by inhibiting AKT/mTOR (Pisanti et al., 2017).
Similarly, CBD reduces oxidative stress, enhances
mitochondrial function, and stimulates G6PDH activity and
the pentose phosphate pathway (PPP) in cerebral ischemia
(Sun et al., 2017). However, enhancing PPP pathway
components in mitochondria, such as G6PDH could, by
reducing oxidative stress, suppress apoptosis and thus enhance
oncogenesis (Redhu and Bhat, 2020). This would begin to explain
why a single compound can both be protective (e.g., in neurons)
and capable of killing cancer cells.
It is possible that CBD directly modulates mitochondrial
function as part of its mode of action. Balance between
reduced nicotinamide adenine dinucleotide (NADH) and
nicotinamide adenine dinucleotide phosphate (NADPH) plays
a key role in balancing oxidative stress. This, in concert with
markers such as reactive oxygen species (ROS), calcium, and
mitochondrial dynamics could be informative in confirming this.
In recent years, 2P-FLIM of the reduced forms of NADH and
NADPH has emerged as a viable means of assessing the redox
state of the cell (Yaseen et al., 2017) and is used to identify
numerous pharmacological, physiological, and
pathophysiological disruptions in NAD+/NADH and NADP+/
NADPH metabolism (Yu and Heikal, 2009; Stringari et al., 2011;
Skala et al., 2007a). The spectral properties of NADH and
NADPH are indistinguishable and are therefore referred to as
NAD(P)H. Moreover, NAD(P)H fluorescence is an effective way
of imaging mitochondria, as NADH is predominantly found in
the mitochondrion (Yu and Heikal, 2009).
NADH is a central cofactor in both anaerobic glycolysis and
aerobic oxidative pathways and plays a critical role in controlling
cellular energy production (Blacker and Duchen, 2016). The
intrinsic fluorescence of NAD(P)H enables two photon
fluorescence lifetime imaging (2P-FLIM) to differentiate
between components of free or bound NAD(P)H species,
thereby reflecting changes in enzymatic function and
representing a potential label-free, direct marker of cellular
metabolism. The excited state lifetime of a molecule allows for
the extraction of additional information, as it is determined by a
wide range of environmental parameters, including oxygen
concentration, pH, ions, molecular binding, and the proximity
to other molecules, making it currently the technique of choice
for functional imaging in live cells and tissue. The use of two-
photon excitation also provides further advantages; for example,
using excitation wavelengths in the near infra-red (NIR) that are
tissue-friendly compared to ultraviolet radiation, decreasing
overall cell and tissue autofluorescence and light scattering,
and improved tissue depth penetration which allows
diffraction limited imaging selectivity, noninvasively confined
to the focal volume (Suhling et al., 2015).
Here we report the use of FLIM to further assess the effects of
CBD on mitochondrial metabolism and morphology in MCF7
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breast adenocarcinoma cells. To achieve this, we used NAD(P)H
autofluorescence by applying 2P-FLIM to provide a label-free
marker of the metabolic state andmitochondrial morphology and




MCF7 cells (from ATCC, provided by Central Laser Facility,
UKRI) were cultured in minimal essential media (MEM),
supplemented with 10% FBS and 1% penicillin/streptomycin.
For the experiments, cells were seeded onto individual dishes or
multiwell plates and treated with 0.005% v/v DMSO (Control) or
1, 5, 10, and 20 µM CBD (Sigma, United Kingdom) for 24 h prior
to assessment at 37°C with 5% CO2 humidified air.
2-Photon Fluorescence Lifetime Imaging
Microscopy
2P-FLIMwas used to image and quantifyNAD(P)H lifetime decay as
a measure of cellular and mitochondrial metabolism. MCF7 cells
were seeded at densities of 1.5 × 105 onto individual glass bottom
dishes (MatTek) and treated as described. Before imaging, cells were
acclimatized for 15min to room temperature. The 2P-FLIM setup
has been described previously (Botchway et al., 2015). Images were
obtained as follows: 750 nm wavelength light for 2-photon excitation
of NADH was generated by a mode-locked titanium sapphire laser
(Mira F900, Coherent Laser Ltd.), producing 180 fs pulses at 76MHz.
This laser was pumped by a solid-state continuous wave 532 nm laser
(Verdi 18, Coherent Lasers Ltd.). Images were collected through a
water immersion 60X 1.2 NA objective on a modified Nikon EC2
confocal scanning system attached to a TE2000-U microscope as
described previously (Botchway et al., 2015). Emission was collected
by the same objective, reflected off a 530 BK-25 filter (Comar Optics,
United Kingdom), passed through a BG39 filter and detected with an
external hybrid GaAsP (HPM-100–40, Becker and Hickl, Germany),
linked to a time correlated single photon counting (TCSPC) module
(SPC830, Becker andHickl, Germany). In this configuration, together
with an average laser power of 0.5mW at the sample, we mostly
observe the fluorescence signal from NAD(P)H with negligible
contribution from the flavins. This was confirmed with solution
phase studies of NAD(P)H and FAD (both purchased from Sigma,
United Kingdom, and used without further purification). We have
performed a dual channel FLIM setup containing BG39 with or
without extra band pass filters (a 440–490 nm band pass filter for
NADH and a 520–570 nm band pass filter for FAD and flavins), and
we did not detect flavin emission in the NADH channel. Solution
concentrations as high as 0.5mM are observed in the flavin-detecting
channel only. The intracellular FAD concentration has been
estimated to be around 8 μM (Kimata et al., 2018). For each of
the five experimental groups (Control, 1, 5, 10, and 20 μmCBD), five
spatially distinct 2P-FLIM images were acquired. Within each image,
five nonoverlapping cells with the highest signal-to-noise ratio were
chosen, equating to 25 cells per treatment group. As NAD(P)H signal
intensity aligns withmitochondrial morphology (See Supplementary
Figure S1), pixels corresponding to the mitochondria or the cytosol
could be manually selected (See Supplementary Figure S2) (the
spatial resolution of the setup was determined to be ∼350 nm) (Alam
et al., 2017). Photon counts of at least 1,000 were used for the
multiexponential analysis, which also excluded nuclear areas from
analysis. The decay curve of each pixel from the 2P-FLIM image was
modeled with a biexponential decay curve, according to Eq. 1, where
I(t) represents fluorescence intensity at time t after the laser pulse.
Goodness of fit was quantified by Chi-squared analysis (See
Supplementary Figure S3). From each pixel two observed
lifetimes were recorded: τFree for free NAD(P)H and τBound for
enzyme-bound NAD(P)H and the contributions of each lifetime
to the overall decay curve, αFree and αBound, respectively (Sharick et al.,
2018; Blignaut et al., 2019).
I(t)  αFreeexp−t/τ1 + αBoundexp−t/τ2 [1]
Mitochondrial Reactive Oxygen Species
and Ca2+
Mitochondrial ROS and Ca2+ levels were quantified using the
MitoSOX Red (ThermoFisher, United Kingdom) and Rhod2
(ThermoFisher, United Kingdom) stains, respectively, in
octuplicate, as per manufacturer’s instructions. Briefly, MCF7
cells were seeded at densities of 3.0 × 104 cells per well. Following
treatment, cells were stained with either 5 µM MitoSOX Red or
1 µM Rhod2 for 30 min. Fluorescence was measured on a
FLUOstar Optima microplate reader (BMG, Germany).
Excitation/Emission: 510/580 nm for MitoSOX Red and 552/
580 nm for Rhod2. Fluorescence intensities were normalized to
total cellular protein, measured using the Bradford assay.
Mitochondrial Morphology Analysis
Mitochondrial morphology was analyzed as previously described
(Valente et al., 2017). Briefly, MCF7 cells were seeded at densities of
1.0 × 105 cells per well and treated with DMSO (Control) or CBD for
24 h as described above. Following treatment, cells were stained with
MitoTracker Deep Red andNucBlue (ThermoFisher, United Kingdom)
and imaged using the ThermoFisher EVOS FL2 Auto using a 40X 0.65
NA plan fluorite objective. Five representative images were selected per
treatment group and within each image, the mitochondria of three
spatially distinct cells were selected for analysis. To quantify CBD-
induced changes in morphology, the cells were analyzed with the
MiNA plugin for ImageJ. This script, following a preprocessing stage
of unsharpmasking, local contrast enhancement (CLAHE), andmedian
filtering, binarized and then skeletonized the mitochondrial image to
produce an output of the mitochondrial footprint (the total area of the
binary image), mean length of mitochondrial networks, mean branch
length per network (the mean of the sum length of individual branches
on separate networks) and mean number of networks. Three cells were
analyzed per image for the five images. This experiment was carried out
in triplicate.
Statistics
Data are presented as box plots, the box shows median with 25th
and 75th percentiles, and the whiskers indicate minimum and
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maximum values. Statistical significance was calculated by one-
way ANOVA with Dunnett’s multiple comparison using
GraphPad Prism version 8.0 (GraphPad Software, La Jolla,
California, United States). An adjusted p < 0.05 was
considered statistically significant.
RESULTS
The significant dose-dependent effects of CBD on the
mitochondrial NAD(P)H lifetime are shown in Figure 1.
Figure1A are representative 2P-FLIM–derived images of
bound NAD(P)H in MCF7 cells 24 h post-treatment with
CBD. Each pixel represents the contribution of bound
NAD(P)H to the overall fluorescence decay, αBound, and is
color-coded between 50% (blue) and 1% (red). The images
indicate a shift from high (blue-green) to lower αBound
(yellow-orange) as the concentration of CBD increases.
Quantitative changes in αBound are shown in Figure 1B. CBD
was found to induce a dose-dependent decrease in αBound
(Control: 25.3 ± 3.9% vs CBD 20 μM: 11.3 ± 4.1%, p < 0.001).
CBD had no significant effect on the fluorescence lifetimes of
mitochondrial free NAD(P)H (τFree) and bound NAD(P)H
(τBound), shown in Figures 1C and D, respectively. The mean
values for each are consistent with the literature that describe free
NAD(P)H as having a shorter lifetime of approximately 0.4 ns
and bound NAD(P)H with a longer lifetime of approximately
2.4 ns. No significant effect of CBD was observed on cytosolic
FIGURE 1 | In vitro effects of cannabidiol on NAD(P)H fluorescence decay as measured by 2P-FLIM. (A) 2P-FLIM–derived images of bound NAD(P)H (αBound).
(B–G) Box plots showing the effect of CBD on (B) mitochondrial αBound NAD(P)H (%), (C) mitochondrial τFree (ps), (D) mitochondrial τBound (ps), (E) cytosolic αBound
NAD(P)H (%), (F) cytosolic τFree (ps), and (G) cytosolic τBound. Box shows median with 25th and 75th percentiles, and whiskers indicate minimum and maximum values.
n  25/group; *  p < 0.05, **  p < 0.01, ***  p < 0.001; data were analyzed by one-way ANOVA with Dunnett’s test for multiple comparisons using GraphPad
Prism (United States).
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levels of αBound NAD(P)H (Figure 1E). CBD had no significant
effect on the fluorescence lifetimes of cytosolic τFree and τBound
(shown in Figures 1F and G, respectively), and this again aligns
with the literature describing the lifetimes of each species.
The in vitro effects of CBD on mitochondrial morphology in
MCF7 cells are shown in Figure 2. Representative images are
shown in Figure 2A. To quantify these changes in mitochondrial
morphology we applied the MiNA plugin to assess the effects of
FIGURE 2 | In vitro effects of cannabidiol on mitochondrial morphology. (A) Representative images showing changes in mitochondrial morphology 24 h
posttreatment with CBD (1, 5, 10, and 20 µM) or the control (DMSO). Cells were stained with MitoTracker Deep Red and NucBlue (ThermoFisher, United Kingdom) and
imaged using the ThermoFisher EVOS FL2. (B–D) Box plots showing the effect of CBD on (B)mitochondrial footprint, (C)mitochondrial network length, and (D) mean
mitochondrial branch length. Box shows median with 25th and 75th percentiles, and whiskers indicate minimum and maximum values. n  45/group; ***  p < 0.001;
data were analyzed by one-way ANOVA with Dunnett’s test for multiple comparisons using GraphPad Prism (United States).
FIGURE 3 | In vitro effects of CBD onmitochondrial ROS andmitochondrial Ca2+ production in MCF7 cells. (A) Effects of cannabidiol (CBD) on normalizedMitoSOX
intensity as a marker of mitochondrial reactive oxygen species (ROS) production. (B) Effects of CBD on normalized Rhod2 intensity as a marker of mitochondrial Ca2+
production. Box shows median with 25th and 75th percentiles, and whiskers indicate minimum and maximum values. n  8/group; **  p < 0.01, ***  p< 0.001; data
were analyzed by one-way ANOVA with Dunnett’s test for multiple comparisons using GraphPad Prism (United States).
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CBD on mitochondrial area (Figure 2B), network length
(Figure 2C), and branch length (Figure 2D). CBD was found
to induce a dose-dependent decrease in the mitochondrial
footprint (control: 436 ± 133 µm2 vs. CBD 20 μM: 214 ±
86 µm2, p < 0.001, Figure 2B), mean network length (control:
2.7 ± 0.3 µm vs. CBD 20 μM: 1.8 ± 0.2 µm, p < 0.001, Figure 2C),
and mean branch length (control: 4.2 ± 0.7 µm vs. CBD 20 μM:
2.4 ± 0.4 µm, p < 0.001, Figure 2D).
The effects of CBD treatment on mitochondrial ROS and
mitochondrial Ca2+ levels are shown in Figures 3A and B,
respectively. Compared to the controls, the highest dose of
CBD significantly increased the mitochondrial levels of both
ROS (Control: 97.6 ± 4.8% vs. CBD 20 μM: 160 ± 53, p <
0.001, Figure 3B) and Ca2+ (Control: 104.6 ± 10.3% vs. CBD
20 μM: 186.9 ± 78.2%, p < 0.01, Figure 3C).
DISCUSSION
In this study we used FLIM, fluorescence microscopy, and
conventional ROS and calcium detecting stains to investigate
the effects of CBD on NAD(P)H lifetime, calcium and ROS levels,
and mitochondrial morphology in a breast cancer cell line. This
study supports the use of FLIM to investigate how CBD may be
working. The observed increase in mitochondrial ROS and
calcium and enhanced mitochondrial fission and changes in
bound NAD(P)H weighting are suggestive of CBD affecting
mitochondrial function.
Studying mitochondrial function may be useful in explaining
the beneficial actions of many natural products. This is reflected
by the link between mitochondrial morphology and function in
both immune cells (Rambold and Pearce, 2018) and cancer (Chen
and Chan, 2017). Critically, many compounds that can suppress
immunity are also antiproliferative; for instance, rapamycin,
which modulates mTOR, is well known to be activated in
cancer (Rad et al., 2018) and a modulator of mitochondrial
function (Wei et al., 2015). In addition to metabolic
reprogramming, mitochondria play a central role in regulating
cell death, and resistance to proapoptotic signaling is a hallmark
of cancer (Sayers, 2011).
Understanding Warburg to Understand
Cannabidiol
A paradox in the understanding of the function of plant products,
including CBD, is how they can enhance survival of normal cells,
yet kill cancer cells. The Warburg shift, or aerobic glycolysis
(Kroemer, 2006; Wallace, 2012), may be key, as it is overall
antiapoptotic and probably key in the earlier stages of
carcinogenesis, as more advanced cancers often upregulate
mitochondrial function. This has led to the so called “Inverse
Warburg Hypothesis”, which, although not fully understood,
suggests that high levels of mitochondrial metabolism underlie
the observed inverse relationship between degenerative diseases
and cancer. Mitochondria are pivotal in the detection of and
adaptation to stress, sending out redox signals in response to
stress, which may be an important mechanism explaining how
plant secondary metabolites work as medicines via a process
called mitohormesis (Tapia, 2006). Critically, evidence is
accumulating that major plant stress signaling compounds,
such as jasmonates, can modulate mitochondria in both plant
and animal cells (Bömer et al., 2020). Moreover, plant
compounds are known to interfere with glycolytic pathways
and major controllers of metabolism, such as VDAC. Thus,
they appear to inhibit carcinogenesis, but if a tumor does
arise, they can alter its mitochondrial phenotype to restore cell
death (Stevens et al., 2018).
Known Mitochondrial Effects for
Cannabidiol–Controlling Calcium Flux
In cancer cells, reduced endoplasmic reticulum–mitochondria
Ca2+ exchange contributes to apoptotic resistance; increased
intracellular Ca2+ contributes to enhanced cell migration,
facilitating metastasis (Marchi and Pinton, 2016). This is
matched by changes in mitochondrial morphology, making
cells more resistant to apoptosis (Senft and Ronai, 2016).
Critically, mitochondrial function is tightly controlled by
calcium, ranging from stimulation to enhance respiration, to
overload to induce cell death (Rossi et al., 2019)—and in
cancer, calcium flow is directed away from the mitochondrion
(Danese et al., 2017).
CBD modulates TRPV1 and calcium influx into the cell and
potentially into the mitochondrion (Ryan et al., 2009; Mato et al.,
2010; Olivas-Aguirre et al., 2019). More directly, CBD has been
shown to bind to and close VDAC1, a major channel responsible
for transporting Ca2+, potentially responsible for the
immunosuppressive and anticancer effects of CBD
(Rimmerman et al., 2013). In leukemic cells, CBD induces
dose-related mitochondrial dysfunction, leading to apoptosis,
which is associated with mitochondrial calcium overload, loss
of mitochondrial membrane potential, and enhanced ROS
production (Olivas-Aguirre et al., 2019). This all supports
earlier data that CBD application can result in mitochondrial
calcium overload and enhanced ROS production (Ryan et al.,
2009; Mato et al., 2010).
Interpreting the FLIM Data
In response to CBD, we identified a dose-dependent decrease in
mitochondrial bound NAD(P)H (αBound). This appears to
indicate reduced activity of the ETC, as the oxidation of
NADH by complex I is the first point where electrons enter
the ETC (Chakraborty et al., 2016). Indeed, comparable
reductions in NAD(P)H αBound have been observed in
response to known mitochondrial toxins and inhibitors such
as potassium cyanide and rotenone (Bird et al., 2005;
Schneckenburger et al., 2004), while in contrast, agents which
increase metabolic activity increase mitochondrial αBound
NAD(P)H (Alam et al., 2017). So, in relation to our data, the
increase in unbound NAD(P)H may represent an inhibition of
the ETC and/or enhanced TCA leading to increased NADH,
possibly coupled to inhibition of glycolysis and enhanced PPP
activity, a generalized inhibition of metabolism leading more
unbound NAD(P)H, and possibly, inhibition of NADP+ binding
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to G6PDH. The latter effect is a known ability of the polyphenol
epigallocatechin gallate (EGCG) (Shin et al., 2008) which also
modulates mitochondrial function (Oliveira et al., 2016).
Inhibition of G6PD has also been observed for other phenolic
compounds (Adem et al., 2014), while many have also been found
to dissociate hexokinase from VDAC1, which inhibits glycolysis
and can enhance apoptosis (Tewari et al., 2015; Tewari et al.,
2017; Goldin et al., 2008). There is thus, perhaps, a generalization
that many of these bioactive plant compounds have the capacity
to induce metabolic reprogramming, which may also apply to
CBD. Whilst the contribution of each species to the decay curve
were affected by CBD treatment, there were no significant
changes in the lifetimes of each species itself (τfree and τBound).
Changes in τBound are often associated with a redistribution of
NAD(P)H binding sites as a result of a shift in metabolic
pathways (Skala et al., 2007b). The absence of changes in this
study may indicate no such pivot in specific metabolic pathways,
although further studies comparing CBD-mediated τfree and
τBound to agents known to perturb mitochondrial metabolism
would be required to validate this.
In terms of intracellular localization, 2P-FLIM permits highly
localized, label-free, sub-micron determination of the redox state,
enabling the differentiation of the mitochondrial redox response
from that of the cytosol. The lack of effect on free or bound
cytosolic NAD(P)H in our results would seem to indicate that the
actions of CBD are mitochondrial specific, which has been
proposed based on the highly lipophilic properties of CBD
(Huestis, 2007; Ryan et al., 2009). However, the subtle,
interconnected relationships between the many cellular
pathways maintaining stores of NADH are not fully
deconvoluted in the aggregate FLIM signal (Blacker and
Duchen, 2016), making full interpretation difficult. For
example, while cancer cells shift their preferred energy-
generating pathway to aerobic glycolysis (Trigos et al., 2018),
the relative rates of glycolysis and OXPHOS do not appear to
affect the intracellular NADH fluorescence lifetime (Blacker and
Duchen, 2016; Guo et al., 2015).
Insight Into Mode of Action
It should be noted that the 24 h post-exposure protocol employed
here was based on our earlier investigations into the actions of
CBD (Kosgodage et al., 2018) and therefore limits our ability to
define an accurate timescale for the specific cascade of
intracellular events following CBD administration. However,
previous studies have indicated that CBD-triggered increases
in Ca2+ precede any mitochondrial changes in ROS,
membrane potential, or morphology (Olivas-Aguirre et al.,
2019). This might suggest a sequential modulation of various
parts of the cells, starting on the outside and working inwards as
this highly lipophilic compound is absorbed by the cell.
Overall, our FLIM data suggest that CBD induces mitochondrial
oxidative stress in these cancer cells, which correlate with the dose-
related increase in mitochondrial ROS and calcium and evidence of
increased mitochondrial fission. Although cancer cells often display
abnormal mitochondrial dynamics, mitochondrial fission is often a
response to oxidative stress, especially if ROS originates from
damaged mitochondria and is associated with a loss of the
mitochondrial membrane potential and influx of calcium,
leading to mitophagy and renewal or cell death (Sharma et al.,
2019). Mitochondrial fission can also form part of a positive
feedback cytosolic calcium signaling pathway that can promote
autophagy, which also seems to be reliant on increased ROS
production (Huang et al., 2019). Mitochondria have a pivotal
role in maintaining cellular homeostasis by sequestering and
releasing intracellular Ca2+. Within the mitochondria, Ca2+
biphasically affects energy metabolism via activation/inhibition of
mitochondrial enzymes and direct charge alteration of the
mitochondrial membrane potential, which in turn regulates the
supply of electrons into the respiratory chain and production of
ROS (Danese et al., 2017). Ultimately however, prolonged
accumulation of mitochondrial calcium, known as calcium
overload, is associated with the mitochondrial permeability
transition (MPT), a key step in the initiation of apoptosis, and
has been identified in T-cells following treatment with CBD
(Olivas-Aguirre et al., 2019). Indeed, these data support our
previous observations of CBD-induced mitochondrial fission in a
different cell line (Nunn et al., 2013) and our unpublished
observations in several other cell lines. Overall, this supports the
concept that CBD can induce ROS in a range of tissue types,
including monocytes (Wu et al., 2018), glioma stem cells (Singer
et al., 2015), and breast cancer cells (Kis et al., 2019).
To explain this, we suggest that CBD triggers calcium uptake via
TRPV and/or release from endoplasmic stores, which is then taken
up by the mitochondrion. In fact, TRPV1 is also expressed
intracellularly, and it has been suggested to play a role in calcium
signaling to the mitochondrion (Nita et al., 2016). Combined with
data that it may alsomodulate VDAC1 (Rimmerman et al., 2013), we
suggest that as CBD is absorbed by the cell, it sequentially modulates
pathways that can result in either enhanced cellular protection or,
potentially, induction of cell death; key in this is both direct and
indirect modulation of mitochondrial function. Support for this
comes from research that indicates that CBD can induce
autophagy, which could be important in epilepsy (Hosseinzadeh
et al., 2016), alcohol-induced liver damage (Yang et al., 2019), and
cancer (Shrivastava et al., 2011). Autophagy is pivotal in maintaining
overall mitochondrial health and involves VDAC1 andmTOR; a key
trigger of the process is mitochondrial dysfunction (Li et al., 2020).
Induction of mitochondrial stress could lead to mitophagy, which in
some cells restores homeostasis, for instance, ensuring inflammation
resolution, but in others, such as cancer cells, it results in death.
Figure 4 summarizes a possible mode of action. A key point here is
that VDAC1 binds many different proteins, including HK and
components of the Bcl2/Bax, so it is also central in controlling cell
fate and a target for cancer treatment (Shoshan-Barmatz et al., 2017).
In broader terms, our data suggest that CBD, as its actions are
often biphasic, could be mitohormetic (Nunn et al., 2020),
inducing sublethal mitochondrial stress that results in an
adaptive response via increased ROS production (Ristow and
Schmeisser, 2014). In cancer cells, being at higher levels of stress
than healthy cells, this tips them into a terminal oxidative stress.
This selectivity has been observed following treatment of T-cells
with CBD, inducing Ca2+ overload and apoptosis in cell lines
derived from acute lymphobastic leukemia of T-lineage, but not
in healthy T-cells (Olivas-Aguirre et al., 2019). This demonstrates
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the potential of CBD in anticancer therapy by “priming” cells,
through sensitizing the mitochondria to respond better to
chemotherapy and hence reducing the severity of treatment
and side effects (Henley et al., 2017; Kosgodage et al., 2018).
CONCLUSION
Overall, our data support a consistent narrative regarding
mitochondrial modulation by CBD. Our results align with
those of previous studies demonstrating that CBD induces
mitochondrial membrane changes that are not too dissimilar
to a reduction in the mitochondrial membrane potential and
the activation of intrinsic apoptotic pathways (Shrivastava
et al., 2011; Wai and Langer, 2016; Olivas-Aguirre et al.,
2019). Finally, we believe that the use of 2P-FLIM could be
unique in unlocking further details of how CBD works, and we
aim to use the technique to study different cell types to
investigate the proposed mechanism further, for example,
understanding its effects on NADH, NADPH, and FAD
lifetimes. In particular, we will seek evidence of biphasic
effects in response to different doses across a range of
timescales.
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FIGURE 4 | Suggested mode of action of CBD, focusing on some of its known targets, and some inferred from other phenolic compounds. CBD may stimulate
calciumuptake into the cell, possibly by channels like TRPV1 and then into themitochondria, whichmay involve VDAC1. It could then eventually inhibit the electron transport
chain (ETC) and potentially induce the release of hexokinase (HK, which binds to VDAC1; VDAC1 is also key in controlling apoptosis via the BCL/BAX system), and either
directly, or indirectly (e.g., by ROS), inhibits other key enzymes in glycolysis, such as G6PDH or GAPDH. This could first stimulate and then inhibit mitochondrial
function, providing a powerful adaptive signal; initially, themitochondrion can swell while it buffers calcium. However, toomuch calcium influxwill eventually lead to overload,
loss of membrane potential, and inhibition of ATP production. If the amount of calcium influx is transient, or not too large, the mitochondrion has a number of adaptive
strategies, such as mitochondrial permeability transition pore flickering (MPTP) to release excessive calcium and upregulation of antioxidant pathways, which could include
the pentose phosphate pathway (PPP). However, if its membrane potential starts to fall, it could start to fission and stimulate mitophagy/autophagy and initially leads to
mitochondrial biogenesis and eventually leads to induction of cell death; rapid fragmentation does seem to predispose to cell death. The key effect will be to switch off
anabolic growth pathways and enhance stress resistance and catabolism, which could be indicated by a shift in bound NAD(P)H. The outcome is thus likely to be
concentration and cell type dependent, as well as dependent on the initial metabolic state of the cell. A key tipping point in relation to cancer is that the sudden influx of
calcium will potentially increase TCA activity and potentially flow through the ETC, which will increase ROS and shift carbohydrate flux away from growth to stress
resistance, for instance, by inhibiting GAPDH. However, cancer cells are generally a lot more reliant on antioxidant defense systems, as generation of ROS is a key driver of
proliferation, so suddenly enhancing mitochondrial ROS is a recognized anticancer strategy as it can tip cancer cells, but not normal cells, toward cell death.
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FIGURE S1 |NAD(P)H autofluorescence andmitochondrial staining overlap.
Representative images of 2P-derived NAD(P)H autofluorescence and MitoTracker
Red-stained MCF7 cells. Superimposed images show the NAD(P)H signal matching
mitochondrial morphology.
FIGURE S2 | Identifying mitochondrial and cytosolic pixels for analysis.
Representative 2P NAD(P)H FLIM image illustrating selection of pixels to be anaylsed.
FIGURE S3 | 2P NAD(P)H FLIM and the Goodness of Fit (Chi Squared).
Representative 2P NAD(P)H FLIM-derived images for each treatment group, colour-
coded to the obtained chi squared value (χ2).
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Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I.,
et al. (2001). Molecular targets for cannabidiol and its synthetic analogues:
effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic
hydrolysis of anandamide. Br. J. Pharmacol. 134 (4), 845–852. doi:10.1038/sj.
bjp.0704327
Blacker, T. S., and Duchen, M. R. (2016). Investigating mitochondrial redox state
using NADH and NADPH autofluorescence. Free Radic. Biol. Med. 100, 53–65.
doi:10.1016/j.freeradbiomed.2016.08.010
Blignaut, M., Loos, B., Botchway, S. W., Parker, A. W., and Huisamen, B. (2019).
Ataxia-Telangiectasia Mutated is located in cardiac mitochondria and impacts
oxidative phosphorylation. Sci. Rep. 9 (1), 4782. doi:10.1038/s41598-019-
41108-1
Bömer, M., Pérez-Salamó, I., Florance, H. V., Salmon, D., Dudenhoffer, J., Finch,
P., et al. (2020). Jasmonates induce Arabidopsis bioactivities selectively
inhibiting the growth of breast cancer cells through CDC6 and mTOR. New
Phytol. 229 (4), 2120–2134. doi:10.1111/nph.17031
Botchway, S. W., Scherer, K. M., Hook, S., Stubbs, C. D., Weston, E., Bisby, R. H.,
et al. (2015). A series of flexible design adaptations to the Nikon E-C1 and E-C2
confocal microscope systems for UV, multiphoton and FLIM imaging.
J. Microsc. 258, 68. doi:10.1111/jmi.12218
Bujak, J. K., Kosmala, D., Szopa, I. M., Majchrzak, K., and Bednarczyk, P. (2019).
Inflammation, cancer and immunity—implication of TRPV1 channel. Front.
Oncol. 9, 1087. doi:10.3389/fonc.2019.01087/full
Chakraborty, S., Nian, F-S., Tsai, J-W., Karmenyan, A., and Chiou, A. (2016).
Quantification of the metabolic state in cell-model of Parkinson’s disease by
fluorescence lifetime imaging microscopy. Sci. Rep. 6, 19145. doi:10.1038/
srep19145
Chen, H., and Chan, D. C. (2017). Mitochondrial dynamics in regulating the
unique phenotypes of cancer and stem cells. Cell Metab. 26 (1), 39–48. doi:10.
1016/j.cmet.2017.05.016
Danese, A., Patergnani, S., Bonora, M., Wieckowski, M. R., Previati, M., Giorgi, C.,
et al. (2017). Calcium regulates cell death in cancer: roles of the mitochondria
and mitochondria-associated membranes (MAMs). Biochim. Biophys. Acta
1858 (8), 615–627. doi:10.1016/j.bbabio.2017.01.003
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., and Darwiche, N. (2015). Cell
death mechanisms of plant-derived anticancer drugs: beyond apoptosis.
Apoptosis 20 (12), 1531–1562. doi:10.1007/s10495-015-1169-2
Gandin, A., Dizengremel, P., and Jolivet, Y. (2021). Integrative role of plant
mitochondria facing oxidative stress: The case of ozone. Plant Physiol.
Biochem. 159, 202–210. doi:10.1016/j.plaphy.2020.12.019
Giorgi, C., Missiroli, S., Patergnani, S., Duszynski, J., Wieckowski, M. R., and
Pinton, P. (2015). Mitochondria-associated membranes: Composition,
molecular mechanisms, and physiopathological implications. Antioxid.
Redox Signal. 22 (12), 995–1019. doi:10.1089/ars.2014.6223
Goldin, N., Arzoine, L., Heyfets, A., Israelson, A., Zaslavsky, Z., Bravman, T., et al.
(2008). Methyl jasmonate binds to and detaches mitochondria-bound
hexokinase. Oncogene 27 (34), 4636–4643. doi:10.1038/onc.2008.108
Gorlach, S., Fichna, J., and Lewandowska, U. (2015). Polyphenols as mitochondria-
targeted anticancer drugs. Cancer Lett. 366 (2), 141–149. doi:10.1016/j.canlet.
2015.07.004
Gray, R. A., Stott, C. G., Jones, N. A., Di Marzo, V., and Whalley, B. J. (2020).
Anticonvulsive properties of cannabidiol in a model of generalized seizure are
transient receptor potential vanilloid 1 dependent. Cannabis Cannabinoid Res.
5 (2), 145–149. doi:10.1089/can.2019.0028
Guard, S. E., Chapnick, D. A., Poss, Z., Ebmeier, C. C., Jacobsen, J., Nemkov, T.,
et al. (2020). Multi-omic analysis reveals cannabidiol disruption of cholesterol
homeostasis in human cell lines. bioRxiv. 10.1101/2020.06.03.130864.
Gugliandolo, A., Pollastro, F., Bramanti, P., and Mazzon, E. (2020). Cannabidiol
exerts protective effects in an in vitro model of Parkinson’s disease activating
AKT/mTOR pathway. Fitoterapia. 143, 104553. doi:10.1101/2020.06.03.130864
Guo, H.-W., Yu, J.-S., Hsu, S.-H., Wei, Y.-H., Lee, O. K., Dong, C.-Y., et al. (2015).
Correlation of NADH fluorescence lifetime and oxidative phosphorylation
metabolism in the osteogenic differentiation of human mesenchymal stem cell.
J. Biomed. Opt. 20 (1), 17004. doi:10.1117/1.JBO.20.1.017004
Henley, A. B., Yang, L., Chuang, K. L., Sahuri-Arisoylu, M., Wu, L. H., Bligh, S. W.
A., et al. (2017). Withania somnifera root extract enhances chemotherapy
through “priming”. PLoS One 12 (1), e0170917. doi:10.1371/journal.pone.
0170917
Hosseinzadeh, M., Nikseresht, S., Khodagholi, F., Naderi, N., and Maghsoudi, N.
(2016). Cannabidiol post-treatment alleviates rat epileptic-related behaviors
and activates hippocampal cell autophagy pathway along with antioxidant
defense in chronic phase of pilocarpine-induced seizure. J. Mol. Neurosci. 58
(4), 432–440. doi:10.1007/s12031-015-0703-6
Huang, L., Yu, L-J., Zhang, X., Fan, B., Wang, F.-Z., Dai, Y.-S., et al. (2019).
Autophagy regulates glucose-mediated root meristem activity by modulating
ROS production in Arabidopsis. Autophagy 15 (3), 407–422. doi:10.1080/
15548627.2018.1520547
Frontiers in Molecular Biosciences | www.frontiersin.org May 2021 | Volume 8 | Article 6301079
Mould et al. Cannabidiol Modulates Mitochondrial Dynamics, Redox
Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chem. Biodivers 4,
1770. doi:10.1002/cbdv.200790152
Iannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A., Soubrane, C., Mazzarella, E., et al.
(2014). Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and
cannabidiol (CBD), activate and desensitize transient receptor potential
vanilloid 1 (TRPV1) channels in Vitro: potential for the treatment of
neuronal hyperexcitability. ACS Chem. Neurosci. 5 (11), 1131–1141. doi:10.
1021/cn5000524
Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., and Whalley, B. J.
(2015). Molecular targets of cannabidiol in neurological disorders.
Neurotherapeutics 12 (4), 699–730. doi:10.1007/s13311-015-0377-3
Kimata, S., Mochizuki, D., Satoh, J., Kitano, K., Kanesaki, Y., Takeda, K., et al.
(2018). Intracellular free flavin and its associated enzymes participate in oxygen
and iron metabolism in Amphibacillus xylanus lacking a respiratory chain.
FEBS Open Bio 8 (6), 947–961. doi:10.1002/2211-5463.12425
Kis, B., Ifrim, F. C., Buda, V., Avram, S., Pavel, I. Z., Antal, D., et al. (2019).
Cannabidiol-from plant to human body: A promising bioactive molecule with
multi-target effects in cancer. Int. J. Mol. Sci. 20 (23), 5905. doi:10.3390/
ijms20235905
Kosgodage, U. S., Mould, R., Henley, A. B., Nunn, A. V., Guy, G. W., Thomas, E. L.,
et al. (2018). Cannabidiol (CBD) is a novel inhibitor for exosome and
microvesicle (EMV) release in cancer. Front. Pharmacol. 9, 889. doi:10.3389/
fphar.2018.00889
Kroemer, G. (2006). Mitochondria in cancer. Oncogene 25, 4630. doi:10.1038/sj.
onc.1209589
Laus, M. N., and Soccio, M. (2020). First evidence of a protective effect of plant
bioactive compounds against H2O2-induced aconitase damage in durumwheat
mitochondria. Antioxidants 9 (12), 1256. doi:10.3390/antiox9121256
Li, X., Zhang, W., Cao, Q., Wang, Z., Zhao, M., Xu, L., et al. (2020). Mitochondrial
dysfunction in fibrotic diseases. Cell Death Discov. Internet 6 (1), 80. doi:10.
1038/s41420-020-00316-9
Marchi, S., and Pinton, P. (2016). Alterations of calcium homeostasis in cancer
cells. Curr. Opin. Pharmacol. 29, 1–6. doi:10.1016/j.coph.2016.03.002
Mato, S., Victoria Sánchez-Gómez, M., andMatute, C. (2010). Cannabidiol induces
intracellular calcium elevation and cytotoxicity in oligodendrocytes. Glia 58
(14), 1739–1747. doi:10.1002/glia.21044
McAllister, S. D., Soroceanu, L., and Desprez, P. Y. (2015). The antitumor activity
of plant-derived non-psychoactive cannabinoids. J. Neuroimmune Pharmacol.
10, 255. doi:10.1007/s11481-015-9608-y
Mechoulam, R., Parker, L. A., and Gallily, R. (2002). Cannabidiol: an overview of
some pharmacological aspects. J. Clin. Pharmacol. 42 (S1), 11S–19S. doi:10.
1002/j.1552-4604.2002.tb05998.x
Nita, I. I., Caspi, Y., Gudes, S., Fishman, D., Lev, S., Hersfinkel, M., et al. (2016).
Privileged crosstalk between TRPV1 channels and mitochondrial calcium
shuttling machinery controls nociception. Biochim. Biophys. Acta 1863 (12),
2868–2880. doi:10.1016/j.bbamcr.2016.09.009
Nunn, A. V., Henley, A., Brody, L. P., and Bell, J. D. (2013). Phytocannabinoids
modulate mitochondrial dynamics in cell lines; stress adaptation. London,
United Kingdom: European Workshop on Cannabinoid Research.
Nunn, A. V. W., Guy, G. W., Botchway, S. W., and Bell, J. D. (2020). From
sunscreens to medicines: can a dissipation hypothesis explain the beneficial
aspects of many plant compounds?. Phytotherapy Res. 34, 1868–1888. doi:10.
1002/ptr.6654
Olivas-Aguirre, M., Torres-López, L., Valle-Reyes, J. S., Hernández-Cruz, A.,
Pottosin, I., and Dobrovinskaya, O. (2019). Cannabidiol directly targets
mitochondria and disturbs calcium homeostasis in acute lymphoblastic
leukemia. Cell Death Dis. 10 (10), 779. doi:10.1038/s41419-019-2024-0
Oliveira, M. R. d., Nabavi, S. F., Daglia, M., Rastrelli, L., and Nabavi, S. M. (2016).
Epigallocatechin gallate and mitochondria—a story of life and death.
Pharmacol. Res. 104, 70–85. doi:10.1016/j.phrs.2015.12.027
O’Connell, B. K., Gloss, D., and Devinsky, O. (2017). Cannabinoids in treatment-
resistant epilepsy: A review. Epilepsy Behav. 70, 341–348. doi:10.1016/j.yebeh.
2016.11.012
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., et al.
(2017). Cannabidiol: state of the art and new challenges for therapeutic
applications. Pharmacol. Ther. 175, 133–150. doi:10.1016/j.pharmthera.2017.02.041
Popov, L. (2020). Mitochondrial biogenesis: An update. J. Cell. Mol. Med. 24 (9),
4892–4899. doi:10.1111/jcmm.15194
Rad, E., Murray, J., and Tee, A. (2018). Oncogenic signalling through mechanistic
target of rapamycin (mTOR): A driver of metabolic transformation and cancer
progression. Cancers 10 (1), 5. doi:10.3390/cancers10010005
Rambold, A. S., and Pearce, E. L. (2018). Mitochondrial dynamics at the interface of
immune cell metabolism and function. Trends Immunol. 39 (1), 6–18. doi:10.
1016/j.it.2017.08.006
Ramer, R., and Hinz, B. (2017). Cannabinoids as anticancer drugs. Adv. Pharmacol.
80, 397–436. doi:10.1016/bs.apha.2017.04.002
Rasouli, H., Farzaei, M. H., Mansouri, K., Mohammadzadeh, S., and Khodarahmi,
R. (2016). Plant cell cancer: may natural phenolic compounds prevent onset and
development of plant cell malignancy? A literature review.Molecules 21 (9), 21.
doi:10.3390/molecules21091104
Redhu, A. K., and Bhat, J. P. (2020). Mitochondrial glucose 6-phosphate
dehydrogenase and 6-phosphogluconate dehydrogenase abrogate p53
induced apoptosis in a yeast model: possible implications for apoptosis
resistance in cancer cells. Biochim. Biophys. Acta Gen. Subj 1864 (3),
129504. doi:10.1016/j.bbagen.2019.129504
Rimmerman, N., Ben-Hail, D., Porat, Z., Juknat, A., Kozela, E., Daniels, M. P., et al.
(2013). Direct modulation of the outer mitochondrial membrane channel,
voltage-dependent anion channel 1 (VDAC1) by cannabidiol: A novel
mechanism for cannabinoid-induced cell death. Cell Death Dis. 4 (12), e949.
doi:10.1038/cddis.2013.471
Ristow, M., and Schmeisser, K. (2014). Mitohormesis: promoting health and
lifespan by increased levels of reactive oxygen species (ROS). Dose Response
12, 288. doi:10.2203/dose-response.13-035.Ristow
Rossi, A., Pizzo, P., and Filadi, R. (2019). Calcium, mitochondria and cell
metabolism: A functional triangle in bioenergetics. Biochim. Biophys. Acta
Mol. Cell. Res. 1866 (7), 1068–1078. doi:10.1016/j.bbamcr.2018.10.016
Ryan, D., Drysdale, A. J., Lafourcade, C., Pertwee, R. G., and Platt, B. (2009).
Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels.
J. Neurosci. 29 (7), 2053–2063. doi:10.1523/JNEUROSCI.4212-08.2009
Sayers, T. J. (2011). Targeting the extrinsic apoptosis signaling pathway for cancer
therapy. Cancer Immunol. Immunother. 60 (8), 1173–1180. doi:10.1007/
s00262-011-1008-4
Schneckenburger, H., Wagner, M., Weber, P., Strauss, W. S., and Sailer, R. (2004).
Autofluorescence lifetime imaging of cultivated cells using a UV picosecond
laser diode. J. Fluoresc 14 (5), 649–654. doi:10.1023/b:jofl.0000039351.09916.cc
Senft, D., and Ronai, Z. A. (2016). Regulators of mitochondrial dynamics in cancer.
Curr. Opin. Cell Biol. 39, 43–52. doi:10.1016/j.ceb.2016.02.001
Sharick, J. T., Favreau, P. F., Gillette, A. A., Sdao, S. M., Merrins, M. J., and Skala, M.
C. (2018). Protein-bound NAD(P)H lifetime is sensitive to multiple fates of
glucose carbon. Sci. Rep. 8 (1), 5456. doi:10.1038/s41598-018-23691-x
Sharma, A., Smith, H. J., Yao, P., and Mair, W. B. (2019). Causal roles of
mitochondrial dynamics in longevity and healthy aging. EMBO Rep. 20
(12), e48395. doi:10.15252/embr.201948395
Shin, E. S., Park, J., Shin, J-M., Cho, D., Cho, S. Y., Shin, D. W., et al. (2008).
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate
dehydrogenase and other enzymes that employ NADP+ as a coenzyme. Bioorg.
Med. Chem. 16 (7), 3580–3586. doi:10.1016/j.bmc.2008.02.030
Shoshan-Barmatz, V., De, S., and Meir, A. (2017). The mitochondrial voltage-
dependent anion channel 1, Ca2+ transport, apoptosis, and their regulation.
Front. Oncol. 7, 60. doi:10.3389/fonc.2017.00060/full
Shoshan-Barmatz, V., Krelin, Y., and Shteinfer-Kuzmine, A. (2018). VDAC1
functions in Ca2+ homeostasis and cell life and death in health and disease.
Cell Calcium 69, 81–100. doi:10.1016/j.ceca.2017.06.007
Shrivastava, A., Kuzontkoski, P. M., Groopman, J. E., and Prasad, A. (2011).
Cannabidiol induces programmed cell death in breast cancer cells by
coordinating the cross-talk between apoptosis and autophagy. Mol. Cancer
Ther. 10 (7), 1161–1172. doi:10.1158/1535-7163.MCT-10-1100
Singer, E., Judkins, J., Salomonis, N., Matlaf, L., Soteropoulos, P., McAllister, S.,
et al. (2015). Reactive oxygen species-mediated therapeutic response and
resistance in glioblastoma. Cell Death Dis. 6, e1601. doi:10.1038/cddis.2014.566
Skala, M. C., Riching, K. M., Bird, D. K., Gendron-Fitzpatrick, A., Eickhoff, J.,
Eliceiri, K. W., et al. (2007a). In vivo multiphoton fluorescence lifetime imaging
of protein-bound and free nicotinamide adenine dinucleotide in normal and
precancerous epithelia. J. Biomed. Opt. 12 (2), 024014. doi:10.1117/1.2717503
Skala, M. C., Riching, K. M., Gendron-Fitzpatrick, A., Eickhoff, J., Eliceiri, K. W.,
White, J. G., et al. (2007b). In vivomultiphoton microscopy of NADH and FAD
Frontiers in Molecular Biosciences | www.frontiersin.org May 2021 | Volume 8 | Article 63010710
Mould et al. Cannabidiol Modulates Mitochondrial Dynamics, Redox
redox states, fluorescence lifetimes, and cellular morphology in precancerous
epithelia. Proc. Natl. Acad. Sci. U.S.A. 104 (49), 19494–19499. doi:10.1073/pnas.
0708425104
Stevens, J. F., Revel, J. S., and Maier, C. S. (2018). Mitochondria-centric review of
polyphenol bioactivity in cancer models. Antioxid. Redox Signal. 29 (16), 1589.
doi:10.1089/ars.2017.7404
Stringari, C., Cinquin, A., Cinquin, O., Digman, M. A., Donovan, P. J., and Gratton,
E. (2011). Phasor approach to fluorescence lifetime microscopy distinguishes
different metabolic states of germ cells in a live tissue. Proc. Natl. Acad. Sci.
U.S.A 108 (33), 13582–13587. doi:10.1073/pnas.1108161108
Suhling, K., Hirvonen, L. M., Levitt, J. A., Chung, P.-H., Tregidgo, C., Le Marois, A.,
et al. (2015). Fluorescence lifetime imaging (FLIM): Basic concepts and some
recent developments.Med. Photon. 27, 3–40. doi:10.1016/j.medpho.2014.12.001
Sun, S., Hu, F., Wu, J., and Zhang, S. (2017). Cannabidiol attenuates OGD/
R-induced damage by enhancing mitochondrial bioenergetics and modulating
glucose metabolism via pentose-phosphate pathway in hippocampal neurons.
Redox Biol. 11, 577–585. doi:10.1016/j.redox.2016.12.029
Tapia, P. C. (2006). Sublethal mitochondrial stress with an attendant
stoichiometric augmentation of reactive oxygen species may precipitate
many of the beneficial alterations in cellular physiology produced by caloric
restriction, intermittent fasting, exercise and dietary phytonutrients:
“Mitohormesis” for health and vitality. Med. Hypotheses 66 (4), 832–843.
doi:10.1016/j.mehy.2005.09.009
Tewari, D., Ahmed, T., Chirasani, V. R., Singh, P. K., Maji, S. K., Senapati, S., et al.
(2015). Modulation of the mitochondrial voltage dependent anion channel
(VDAC) by curcumin. Biochim. Biophys. Acta 1848, 151–158. doi:10.1016/j.
bbamem.2014.10.014
Tewari, D., Majumdar, D., Vallabhaneni, S., and Bera, A. K. (2017). Aspirin induces
cell death by directly modulating mitochondrial voltage-dependent anion
channel (VDAC). Sci. Rep. 7 (1), 45184. doi:10.1038/srep45184
Trigos, A. S., Pearson, R. B., Papenfuss, A. T., and Goode, D. L. (2018). How the
evolution of multicellularity set the stage for cancer. Br. J. Cancer 118 (2),
145–152. doi:10.1038/bjc.2017.398
Valente, A. J., Maddalena, L. A., Robb, E. L., Moradi, F., and Stuart, J. A. (2017). A
simple ImageJ macro tool for analyzing mitochondrial network morphology in
mammalian cell culture. Acta Histochem. 119 (3), 315–326. doi:10.1016/j.acthis.
2017.03.001
Wai, T., and Langer, T. (2016). Mitochondrial dynamics and metabolic regulation.
Trends Endocrinol. Metab. 212 (4), 379–387. doi:10.1016/j.tem.2015.12.001
Wallace, D. C. (2012). Mitochondria and cancer. Nat. Rev. Cancer 12 (10),
685–698. doi:10.1038/nrc3365
Wei, Y., Zhang, Y.-J., Cai, Y., and Xu, M.-H. (2015). The role of mitochondria in
mTOR-regulated longevity. Biol. Rev. Camb. Philos. Soc. 90 (1), 167–181.
doi:10.1111/brv.12103
Wu, H.-Y., Huang, C.-H., Lin, Y.-H., Wang, C.-C., and Jan, T.-R. (2018).
Cannabidiol induced apoptosis in human monocytes through mitochondrial
permeability transition pore-mediated ROS production. Free Radic. Biol. Med.
124, 311–318. doi:10.1016/j.freeradbiomed.2018.06.023
Yang, L., Yang, C., Thomes, P. G., Kharbanda, K. K., Casey, C. A., McNiven, M. A.,
et al. (2019). Lipophagy and alcohol-induced fatty liver. Front. Pharmacol. 10,
495. doi:10.3389/fphar.2019.00495/full
Yaseen, M. A., Sutin, J., Wu, W., Fu, B., Uhlirova, H., Devor, A., et al. (2017).
Fluorescence lifetimemicroscopy of NADH distinguishes alterations in cerebral
metabolism in vivo. Biomed. Opt. Express 8 (5), 2368–2385. doi:10.1364/BOE.8.
002368
Yu, Q., and Heikal, A. A. (2009). Two-photon autofluorescence dynamics imaging
reveals sensitivity of intracellular NADH concentration and conformation to
cell physiology at the single-cell level. J. Photochem. Photobiol. B. 95 (1), 46–57.
doi:10.1016/j.jphotobiol.2008.12.010
Conflict of Interest:GG is the founder and chairman of GW Pharmaceuticals, and
AN is a consultant to GW Pharmaceuticals.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2021 Mould, Botchway, Parkinson, Thomas, Guy, Bell and Nunn. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums is
permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Molecular Biosciences | www.frontiersin.org May 2021 | Volume 8 | Article 63010711
Mould et al. Cannabidiol Modulates Mitochondrial Dynamics, Redox
